NCMP-13. BRAIN MRI FINDINGS IN PATIENTS TREATED WITH CHIMERIC ANTIGEN RECEPTOR T-CELLS (CAR-T) DURING SEVERE NEUROTOXICITY

INTRODUCTION: Severe neurotoxicity occurs in ~30% of Diffuse Large B Cell Lymphoma (DLBCL) patients treated with CAR-T cell therapy. Brain MRI is used to assess and manage patients during neurotoxicity. Brain MRI can help understand which brain locations are affected during neurotoxicity. However, i...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Neuro Oncol
Glavni autori: Mokhtari, Sepideh, Arrington, John, Asquith, Justin, Bachmeier, Christina, Locke, Frederick, Lazaryan, Aleksandr
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2019
Teme:
Neurological Complications of Cancer and Cancer Therapy
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847810/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.759
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items